AU2388392A - Oxicam or oxicam derivatives-containing ophthalmic compositions - Google Patents

Oxicam or oxicam derivatives-containing ophthalmic compositions

Info

Publication number
AU2388392A
AU2388392A AU23883/92A AU2388392A AU2388392A AU 2388392 A AU2388392 A AU 2388392A AU 23883/92 A AU23883/92 A AU 23883/92A AU 2388392 A AU2388392 A AU 2388392A AU 2388392 A AU2388392 A AU 2388392A
Authority
AU
Australia
Prior art keywords
oxicam
compositions
ophthalmic compositions
derivatives
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23883/92A
Inventor
Gerard Schwadrohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LABORATOIRE EUROPHTA SA
Original Assignee
LABORATOIRE EUROPHTA SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LABORATOIRE EUROPHTA SA filed Critical LABORATOIRE EUROPHTA SA
Publication of AU2388392A publication Critical patent/AU2388392A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novel pharmaceutical compositions for ophthalmic use, particularly instillable ophthalmic compositions having average viscosity and characterized in that they contain, as the active principle, an anti-flammatory agent which is optionally combined with an antibacterial agent, a gellable acrylic acid polymer and a basic agent to form a fluid aqueous solute with a pH of 7.0-8.0. The compositions are useful for treating inflammatory diseases of the eyeball.
AU23883/92A 1991-07-18 1992-07-17 Oxicam or oxicam derivatives-containing ophthalmic compositions Abandoned AU2388392A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9109096 1991-07-18
FR9109096A FR2679135B1 (en) 1991-07-18 1991-07-18 NOVEL OPHTHALMIC COMPOSITIONS WITH IMPROVED ADHESIVITY AND METHODS OF PREPARING THE SAME.

Publications (1)

Publication Number Publication Date
AU2388392A true AU2388392A (en) 1993-02-23

Family

ID=9415269

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23883/92A Abandoned AU2388392A (en) 1991-07-18 1992-07-17 Oxicam or oxicam derivatives-containing ophthalmic compositions

Country Status (10)

Country Link
EP (1) EP0594770B1 (en)
AT (1) ATE147627T1 (en)
AU (1) AU2388392A (en)
DE (1) DE69216831T2 (en)
DK (1) DK0594770T3 (en)
ES (1) ES2099272T3 (en)
FI (1) FI107700B (en)
FR (1) FR2679135B1 (en)
NO (1) NO940160L (en)
WO (1) WO1993001814A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (en) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
EP1007049A1 (en) * 1997-08-27 2000-06-14 Hexal AG New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
JP4234907B2 (en) * 1998-05-15 2009-03-04 わかもと製薬株式会社 Anti-inflammatory eye drops
AU1548001A (en) * 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1649858A1 (en) * 2003-07-10 2006-04-26 Arturo Jimenez Bayardo Method of preparing an aqueous meloxicam solution and aqueous solution thus produced
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
BRPI0720434A2 (en) * 2006-12-22 2014-01-07 Sigma Tau Ind Farmaceuti USEFUL GEL FOR OPHTHALMIC PHARMACEUTICAL RELEASE
CA2777366C (en) 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
JPS5913714A (en) * 1982-07-13 1984-01-24 Taito Pfizer Kk Antiphlogistic and analgesic agent for external use

Also Published As

Publication number Publication date
WO1993001814A1 (en) 1993-02-04
EP0594770A1 (en) 1994-05-04
FR2679135B1 (en) 1995-05-19
FI107700B (en) 2001-09-28
ES2099272T3 (en) 1997-05-16
FR2679135A1 (en) 1993-01-22
DK0594770T3 (en) 1997-07-21
FI940224A0 (en) 1994-01-17
NO940160L (en) 1994-03-04
DE69216831D1 (en) 1997-02-27
ATE147627T1 (en) 1997-02-15
NO940160D0 (en) 1994-01-17
FI940224A (en) 1994-03-14
DE69216831T2 (en) 1997-07-31
EP0594770B1 (en) 1997-01-15

Similar Documents

Publication Publication Date Title
AU2388392A (en) Oxicam or oxicam derivatives-containing ophthalmic compositions
DK0418339T3 (en) Preparation and Method for Preventing Tissues Between Body Tissues
ES8802091A1 (en) Improved disinfecting and preserving solutions for contact lenses and methods of use.
ATE402712T1 (en) SYNERGISTIC ANTIMICROBIAL OPHTHALMIC PREPARATIONS WITH CHLORITE AND HYDROGEN PEROXIDE
RU93056633A (en) ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE
BR9914128A (en) Antibiotic compositions for treatment of the eye, ear and nose
DE69526369D1 (en) ANTI-INFLAMMATORY EYE DROPS
NZ500300A (en) Compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid for the treatment of excessive proliferation of retinal pigment epithelial cells
AU2360592A (en) Polyacrylic acid based ophthalmic compositions
MY103079A (en) New ophtalmological composition of matter
ATE249225T1 (en) AGENT CONTAINING MANNOSE-6-PHOSPHATE AND USE THEREOF IN THE TREATMENT OF FIBROTIC DISEASES
DK0639049T3 (en) Halogenated 4'-methoxyacetophenones as microbicides and preservatives
NO940064L (en) Eye preparation on polyacrylic acid basis
MC2217A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPTALMOLOGICAL USE CONTAINING HEXETIDINE OR ITS DERIVATIVES OR SALTS
PT711163E (en) USE OF BENZIDAMINE IN THE TREATMENT OF TNF-INDUCED PATHOLOGICAL STATES
AU9095291A (en) Sterilising composition
JPS5762219A (en) Ophthalmic solution
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES